Double Point Ventures invests in companies developing cutting-edge therapeutics, from gene therapies to precision medicines. While the primary focus is on novel drugs, innovative early revenue-stage diagnostic firms, medical device startups, digital health companies, and healthcare service providers that are shaping the future of healthcare are also targeted. Backed by visionary investors, the mission is clear: to finance the scientific pioneers unraveling the medical enigmas of this era.
Focus Areas
Investment Types
Notable Investments
